AU7471098A - Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents - Google Patents

Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents

Info

Publication number
AU7471098A
AU7471098A AU74710/98A AU7471098A AU7471098A AU 7471098 A AU7471098 A AU 7471098A AU 74710/98 A AU74710/98 A AU 74710/98A AU 7471098 A AU7471098 A AU 7471098A AU 7471098 A AU7471098 A AU 7471098A
Authority
AU
Australia
Prior art keywords
antitum
agents
associated antigens
influenza viruses
expressing tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74710/98A
Inventor
Adolfo Garcia-Sastre
Peter Palese
Nicholas P Restifo
Steven A Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institutes of Health NIH
Icahn School of Medicine at Mount Sinai
Original Assignee
National Institutes of Health NIH
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institutes of Health NIH, Mount Sinai School of Medicine filed Critical National Institutes of Health NIH
Publication of AU7471098A publication Critical patent/AU7471098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16141—Use of virus, viral particle or viral elements as a vector
    • C12N2760/16143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU74710/98A 1997-04-30 1998-04-30 Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents Abandoned AU7471098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4517697P 1997-04-30 1997-04-30
US60045176 1997-04-30
PCT/US1998/008929 WO1998048834A1 (en) 1997-04-30 1998-04-30 Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

Publications (1)

Publication Number Publication Date
AU7471098A true AU7471098A (en) 1998-11-24

Family

ID=21936417

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74710/98A Abandoned AU7471098A (en) 1997-04-30 1998-04-30 Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents

Country Status (2)

Country Link
AU (1) AU7471098A (en)
WO (1) WO1998048834A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2372699A1 (en) * 1999-05-07 2000-11-16 Steven K. Libutti Methods for treating tumors using antiangiogenic compounds
US7968101B2 (en) 2004-11-19 2011-06-28 Wisconsin Alumni Research Foundation Recombinant influenza vectors with tandem transcription units
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
EP2708552A1 (en) 2012-09-12 2014-03-19 Medizinische Universität Wien Influenza virus
WO2015196150A2 (en) 2014-06-20 2015-12-23 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
CN113874496A (en) 2019-02-08 2021-12-31 威斯康星校友研究基金会(Warf) Humanized cell lines
EP4022046A2 (en) 2019-08-27 2022-07-06 Wisconsin Alumni Research Foundation (WARF) Recombinant influenza viruses with stabilized ha for replication in eggs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2084180A1 (en) * 1991-12-11 1993-06-12 Paul P. Hung Expression of specific immunogens using viral antigens

Also Published As

Publication number Publication date
WO1998048834A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
AU6065998A (en) Influenza vaccine
AU9623898A (en) Vaccines
AU8828598A (en) Retrovirus and viral vectors
AU2678097A (en) Targeted viral vectors
EP1074251A4 (en) Adhesive preparations
AU1951201A (en) Peptide antigens
AU7069198A (en) Collimator
AU3328900A (en) Influenza virus hemagglutinin-binding peptides
AU5184398A (en) Locomotive adhesion enhancing material mixtures
AU7471098A (en) Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents
AU5953598A (en) Plaque-inhibiting composites
AU9256898A (en) Methoximinomethyloxadiazines used as pesticides
AU9105698A (en) Rab proteins
AU7572198A (en) Tumor-associated antigen
AU5216198A (en) Transgenic virus
AU6000698A (en) Proteins
AU7915398A (en) An influenza enveloped dna vaccine
AU6275098A (en) Novel h-rev 107-like protein
AU8095598A (en) Hair-drier or the like
AU2232399A (en) Recombinant ctb-based vaccines
GB9702990D0 (en) Virus vaccine
AU2691400A (en) Virus vector
AU1991095A (en) Activating virus
AU4399197A (en) Hepatitis c virus epitope
AU6601098A (en) Vaccine and assay

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase